AAAAAA

   
Results: 1-12 |
Results: 12
Recent advances in immunosuppressive therapy for renal transplantation
Authors: Peddi, VR First, MR
Citation: Vr. Peddi et Mr. First, Recent advances in immunosuppressive therapy for renal transplantation, SEMIN DIAL, 14(3), 2001, pp. 218-222
Immediate allograft dysfunction due to atheroembolic disease
Authors: Chaudhury, PR Alexander, JW First, MR Peddi, VR Munda, R Cavallo, T
Citation: Pr. Chaudhury et al., Immediate allograft dysfunction due to atheroembolic disease, AM J KIDNEY, 37(2), 2001, pp. 423-426
Early posttransplant care of renal transplant recipients
Authors: Peddi, VR First, MR
Citation: Vr. Peddi et Mr. First, Early posttransplant care of renal transplant recipients, SEMIN DIAL, 12(5), 1999, pp. 320-328
Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry
Authors: Hariharan, S Adams, MB Brennan, DC Davis, CL First, MR Johnson, CP Ouseph, R Peddi, VR Pelz, C Roza, AM Vincenti, F George, V
Citation: S. Hariharan et al., Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry, TRANSPLAN P, 31(1-2), 1999, pp. 223-224
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune
Authors: First, MR Weiskittel, P Burton, ML Shah, MB Dreyer, D Fleck, P Bey, C Peddi, VR Canafax, DM Schroeder, TJ
Citation: Mr. First et al., Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune, TRANSPLAN P, 31(1-2), 1999, pp. 324-325
Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation
Authors: Peddi, VR Munda, R Demmy, AM First, MR
Citation: Vr. Peddi et al., Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation, TRANSPLAN P, 31(1-2), 1999, pp. 608-609
Graft outcome in patients with biopsy-proven chronic renal allograft rejection
Authors: Peddi, VR Schroeder, TJ Weiskittel, P First, MR
Citation: Vr. Peddi et al., Graft outcome in patients with biopsy-proven chronic renal allograft rejection, TRANSPLAN P, 31(1-2), 1999, pp. 1308-1309
Recurrent and de novo glomerular disease after renal transplantation - A report from Renal Allograft Disease Registry (RADR)
Authors: Hariharan, S Adams, MB Brennan, DC Davis, CL First, MR Johnson, CP Ouseph, R Peddi, VR Pelz, CJ Roza, AM Vincenti, F George, V
Citation: S. Hariharan et al., Recurrent and de novo glomerular disease after renal transplantation - A report from Renal Allograft Disease Registry (RADR), TRANSPLANT, 68(5), 1999, pp. 635-641
A blinded retrospective analysis of renal allograft pathology using the banff schema - Implications for clinical management
Authors: Dean, DE Kamath, S Peddi, VR Schroeder, TJ First, MR Cavallo, T
Citation: De. Dean et al., A blinded retrospective analysis of renal allograft pathology using the banff schema - Implications for clinical management, TRANSPLANT, 68(5), 1999, pp. 642-645
Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
Authors: First, MR Weiskittel, P Shah, M Peddi, VR Canafax, D Schroeder, TJ
Citation: Mr. First et al., Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method, TRANSPLAN P, 30(8), 1998, pp. 3955-3957
Tacrolimus use in kidney-pancreas recipients is associated with less acuterenal dysfunction than cyclosporine
Authors: Fleck, PR Schroeder, TJ Dauod, AJ Peddi, VR First, MR
Citation: Pr. Fleck et al., Tacrolimus use in kidney-pancreas recipients is associated with less acuterenal dysfunction than cyclosporine, TRANSPLAN P, 30(8), 1998, pp. 4070-4072
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus
Authors: Daoud, AJ Schroeder, TJ Shah, M Hariharan, S Peddi, VR Weiskittel, P First, MR
Citation: Aj. Daoud et al., A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus, TRANSPLAN P, 30(8), 1998, pp. 4079-4081
Risultati: 1-12 |